康缘药业
(600557)
| 流通市值：114.54亿 | | | 总市值：115.78亿 |
| 流通股本：5.78亿 | | | 总股本：5.85亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,359,020,285.93 | 4,867,806,702.4 | 3,496,031,021.85 | 2,553,167,904.18 |
| 营业收入 | 1,359,020,285.93 | 4,867,806,702.4 | 3,496,031,021.85 | 2,553,167,904.18 |
| 二、营业总成本 | 1,187,013,990.73 | 4,359,915,092.72 | 3,101,831,386.37 | 2,233,196,147.97 |
| 营业成本 | 345,110,322.75 | 1,252,521,178.25 | 919,745,227.42 | 639,568,560 |
| 税金及附加 | 21,545,793.11 | 74,782,203.45 | 54,593,231.82 | 39,430,873.81 |
| 销售费用 | 508,857,832.21 | 1,936,943,796.67 | 1,483,242,853.03 | 1,088,665,320.81 |
| 管理费用 | 116,513,658.07 | 347,037,709.33 | 149,541,307.8 | 109,951,685.18 |
| 研发费用 | 204,124,846.95 | 771,690,071.27 | 510,005,109.32 | 363,451,324.29 |
| 财务费用 | -9,138,462.36 | -23,059,866.25 | -15,296,343.02 | -7,871,616.12 |
| 其中:利息费用 | - | - | - | 32,777.24 |
| 其中:利息收入 | 9,327,632.67 | 24,454,690.7 | 16,394,420.11 | 8,346,425.4 |
| 加:投资收益 | 6,033,417.99 | 14,794,029.67 | 6,608,460.58 | 932,069.18 |
| 资产处置收益 | -55,324.11 | 757,741.43 | -28,865.72 | -28,865.72 |
| 资产减值损失(新) | - | -2,771,458.16 | - | - |
| 信用减值损失(新) | -690,851.09 | -120,013.6 | -1,103,320.38 | -1,870,988.15 |
| 其他收益 | 5,301,145.82 | 43,240,484.2 | 47,387,851.46 | 23,225,145.98 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 182,594,683.81 | 563,792,393.22 | 447,063,761.42 | 342,229,117.5 |
| 加:营业外收入 | 954,064.37 | 6,155,189.18 | 1,404,107.27 | 1,080,475.06 |
| 减:营业外支出 | 5,947,210.04 | 18,964,979.03 | 13,424,959.34 | 8,563,193.77 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 177,601,538.14 | 550,982,603.37 | 435,042,909.35 | 334,746,398.79 |
| 减:所得税费用 | 28,033,953.26 | 3,932,331.59 | 75,289,105.73 | 51,857,363.82 |
| 六、净利润 | 149,567,584.88 | 547,050,271.78 | 359,753,803.62 | 282,889,034.97 |
| 持续经营净利润 | 149,567,584.88 | 547,050,271.78 | 359,753,803.62 | 282,889,034.97 |
| 归属于母公司股东的净利润 | 148,044,958.72 | 536,732,878.37 | 349,526,250.72 | 275,720,868.32 |
| 少数股东损益 | 1,522,626.16 | 10,317,393.41 | 10,227,552.9 | 7,168,166.65 |
| (一)基本每股收益 | 0.26 | 0.93 | 0.61 | 0.47 |
| (二)稀释每股收益 | 0.25 | 0.93 | 0.6 | 0.47 |
| 九、综合收益总额 | 149,567,584.88 | 547,050,271.78 | 359,753,803.62 | 282,889,034.97 |
| 归属于母公司股东的综合收益总额 | 148,044,958.72 | 536,732,878.37 | 349,526,250.72 | 275,720,868.32 |
| 归属于少数股东的综合收益总额 | 1,522,626.16 | 10,317,393.41 | 10,227,552.9 | 7,168,166.65 |
| 公告日期 | 2024-04-13 | 2024-03-11 | 2023-10-26 | 2023-07-13 |
| 审计意见(境内) | | 标准无保留意见 | | |